https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00331-0/fulltext#appsec1
Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study
Erhöhung 266% (aHR).
SARS-2 Autoimmune Risk
MS 266%
Pemphigoid 239%
Anti-phospholipid antibody SD 212%
Immune mediated thrombocytopenia 210%
Pernicious anaemia 172%
Vasculitis 146%
Other arthritis 143%
Psoriasis 142%
Spondyloarthritis 132%
Graves D 130%
Rheumatoid arthritis 129%